Genetic testing in children with surfactant dysfunction

Archives of Disease in Childhood

Volumn 98, Issue 7, 2013, Pages 490-496

  Turcu, Simona ^a,b   Ashton, Emma ^a   Jenkins, Lucy ^a   Gupta, Atul ^c   Mok, Quen ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; AZATHIOPRINE; DEXAMETHASONE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISOLONE; SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; EXTRACORPOREAL OXYGENATION; GENETIC COUNSELING; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; INTERSTITIAL LUNG DISEASE; MUTATIONAL ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PATIENT REFERRAL; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SURFACTANT PROTEIN DYSFUNCTION; THORAX RADIOGRAPHY; UNITED KINGDOM;

GENETIC TESTING; PAEDIATRIC LUNG DISEASE; SURFACTANT DYSFUNCTION;

ATP-BINDING CASSETTE TRANSPORTERS; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; LONDON; LUNG; LUNG DISEASES; MALE; MUTATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C;

EID: 84879692302     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-303166     Document Type: Article

References (10)

1. Gower WA, Nogee LM, Surfactant dysfunction. Paediatr Respir Rev 2011;12:223-9.
2. Wert S, Whitsett J, Nogee L, Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12:253-74.
3. Nogee LM, Genetics of pediatric interstitial lung disease. Curr Opin Pediatr 2006;18:287 -92.
4. Faro A, Hamvas A, Lung transplantation for inherited disorders of surfactant metabolism. Neo Reviews 2008;9:e468-76.
5. Doan Ml, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008;63:366-73.
6. Guillot L, Carre A, Szinnai G, et al. NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome". Hum Mutat 2010;31:e1146-62.
7. Doan ML, Elidemir O, Dishop MK, et al. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax 2009;64:677 -81.
8. Thouvenin G, Taam R, Flamein F, et al. Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010;95:449-54.
9. Gower WA, Wert SE, Ginsberg JS, et al. Fatal familial lung disease caused by ABCA3 deficiency without identified ABCA3 mutations. J Pediatr 2010;157:62-8.
10. Peca D, Petrini S, Tzialla C, et al. Altered surfactant homeostasis and recurrent respiratory failure secondary to TTF-1 nuclear targeting defect. Respir Res 2011;12:115.